-
公开(公告)号：US09180123B2
公开(公告)日：2015-11-10
申请号：US14656123
申请日：2015-03-12
Applicant: Pfizer Inc.
Inventor： Matthew Frank Brown , Ye Che , Anthony Marfat , Michael Joesph Melnick , Justin Ian Montgomery , Usa Reilly
IPC: C07D401/00 , A61K31/4412 , A61K31/4439
CPC classification number: A61K31/4412 , A61K31/4439 , C07D211/86 , C07D213/64 , C07D401/04 , C07D401/08 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/10 , C07D409/04 , C07D413/10 , C07D413/12 , C07D417/04 , C07D417/10 , C07D417/12 , Y02A50/473
Abstract: The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
Abstract translation: 本发明涉及一类新的异羟肟酸衍生物，它们用作LpxC抑制剂，更具体地说是它们用于治疗细菌感染的用途。
-
公开(公告)号：US20150182513A1
公开(公告)日：2015-07-02
申请号：US14656123
申请日：2015-03-12
Applicant: Pfizer Inc.
Inventor： Matthew Frank Brown , Ye Che , Anthony Marfat , Michael Joesph Melnick , Justin Ian Montgomery , Usa Reilly
IPC: A61K31/4412 , A61K31/4439
CPC classification number: A61K31/4412 , A61K31/4439 , C07D211/86 , C07D213/64 , C07D401/04 , C07D401/08 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/10 , C07D409/04 , C07D413/10 , C07D413/12 , C07D417/04 , C07D417/10 , C07D417/12 , Y02A50/473
Abstract: The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
Abstract translation: 本发明涉及一类新的异羟肟酸衍生物，它们用作LpxC抑制剂，更具体地说是它们用于治疗细菌感染的用途。
-
公开(公告)号：US09018384B2
公开(公告)日：2015-04-28
申请号：US14447788
申请日：2014-07-31
Applicant: Pfizer Inc.
Inventor： Matthew Frank Brown , Ye Che , Anthony Marfat , Michael Joesph Melnick , Justin Ian Montgomery , Usa Reilly
IPC: A61K31/44 , C07D401/00 , C07D213/64 , C07D401/04 , C07D401/08 , C07D401/10 , C07D401/12 , C07D405/04 , C07D405/10 , C07D409/04 , C07D413/10 , C07D413/12 , C07D417/04 , C07D417/10 , C07D417/12 , C07D211/86 , C07D403/04 , C07D401/14
CPC classification number: A61K31/4412 , A61K31/4439 , C07D211/86 , C07D213/64 , C07D401/04 , C07D401/08 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/10 , C07D409/04 , C07D413/10 , C07D413/12 , C07D417/04 , C07D417/10 , C07D417/12 , Y02A50/473
Abstract: The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
-
公开(公告)号：US20140343031A1
公开(公告)日：2014-11-20
申请号：US14447788
申请日：2014-07-31
Applicant: Pfizer Inc.
Inventor： Matthew Frank Brown , Ye Che , Anthony Marfat , Michael Joesph Melnick , Justin Ian Montgomery , Usa Reilly
IPC: C07D213/64 , C07D401/12 , C07D401/14 , C07D401/04 , C07D413/10 , C07D401/10 , C07D405/04
CPC classification number: A61K31/4412 , A61K31/4439 , C07D211/86 , C07D213/64 , C07D401/04 , C07D401/08 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/10 , C07D409/04 , C07D413/10 , C07D413/12 , C07D417/04 , C07D417/10 , C07D417/12 , Y02A50/473
Abstract: The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
Abstract translation: 本发明涉及一类新的异羟肟酸衍生物，它们用作LpxC抑制剂，更具体地说是它们用于治疗细菌感染的用途。
-
-
-
Search Results
4
records
(took 0.025 seconds)
